Dermata Therapeutics, Inc. (DRMAW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
アナリスト予想 一株当たり利益（EPS） $-147.80 および 売上高 $0.00B 来期予想.
一株当たり利益（EPS）実績推移: 2024: 実績 $-8,032.22 vs 予想 $-147.80 (下回る -5334.5%). 2025: 実績 $-8.16 vs 予想 $-8.00 (下回る -2%). アナリスト精度: 50%.
